Get Premium to unlock powerful stock data
OTCPK:MYCOF (Canada)  
Mydecine Innovations Group Inc logo

Mydecine Innovations Group Inc

$ 0.64 -0.06 (-8.57%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 3.40M
Enterprise V:
$ 6.44M
Volume:
23.44K
Avg Vol (2M):
22.24K
Also Trade In:
Volume:
23.44K
Market Cap $:
3.40M
PE Ratio:
At Loss
Avg Vol (2-Month):
22.24K
Enterprise Value $:
6.44M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Mydecine Innovations Group Inc
NAICS : 325411 SIC : 3741
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Description
Mydecine Innovations Group Inc is a biopharma and life sciences company. It is committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use. Reinforcing Mydecine's commitment to mental health solutions is underpinned by the company's three main focuses: Clinical Trials focusing on Veterans, EMS, and First Responders with a PTSD indication; Research and Development building a robust portfolio of intellectual property around drug discovery and unique delivery mechanisms with relevant use patents and future patent applications and Modern technology utilizing for better clinical trial management and mental health wellbeing.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.06
Equity-to-Asset -0.71
Debt-to-Equity -1.31
Debt-to-EBITDA -0.54
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -43.96
Distress
Grey
Safe
Beneish M-Score 1.14
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.52
9-Day RSI 41.24
14-Day RSI 40.24
6-1 Month Momentum % -86.75
12-1 Month Momentum % -95.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.75
Quick Ratio 0.75
Cash Ratio 0.06
Days Sales Outstanding 1022

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -233.4

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -168820
Net Margin % -188260
ROE % -117.7
ROA % -69.13
ROIC % -118.31
ROC (Joel Greenblatt) % -636.94
ROCE % -88.8

Financials

MYCOF's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:MYCOF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.004
EPS (TTM) ($) -1.766
Beta 4.79
Volatility % 97.33
14-Day RSI 40.24
14-Day ATR ($) 0.221657
20-Day SMA ($) 0.747775
12-1 Month Momentum % -95.29
52-Week Range ($) 0.05 - 110
Shares Outstanding (Mil) 5.22

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Mydecine Innovations Group Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More